Era-by-era improvement in survival for elderly patients with Hodgkin lymphoma; outcome data from a large population-based cohort.

subjected to pelvic radiation therapy was named as radiation recall syndrome induced by CBZ [3]. In previous case series, differential diagnosis of hematuria induced by disease progression was eliminated by TURB. In our patient, this adverse event was an unexpected reaction to CBZ. The mechanism of this reaction to CBZ is not known as yet. Seventeen percent hematuria of all grades was found in the CBZ arm of the TROPIC, and the metabolism of CBZ, which occurs mainly in the liver, does not provide an explanation for the occurrence of hemorrhagic cystitis [4]. During gross hematuria, he had no coagulation disorder or liver dysfunction. Adverse reaction report was performed by the manufacturer to the Pharmaceuticals and Medical Devices Agency in Japan. Our case may guide management of patients with gross hematuria after the treatments with CBZ and suggests the importance of urological investigation with drug withdrawal.